Post on 03-Jan-2016
description
CHRONIC FATIGUE/DEPRESSIONTHE MIND BODY CONNECTION
AIMGP Seminar Series
2003-2004
Tim Cook
(H. Abrams)
OUTLINE1. Case2. Functional Somatic Syndromes3. CFS Diagnostic Criteria 4. CFS Diagnostic Strategy5. CFS Treatment Strategy: Evidence?6. Depression Epidemiology7. Depression Management
CASE
33 yo woman VP HR Referred from FDr c/o fatigue X 18
mos MEDS
multivits, CoE Q10, Gingko, glucosamine Prn Zomig, Tylenol, Zelnorm
Non-smoker, daily glass wine, quit exercising
Case Cont’d
P/E – fit looking woman Few tender, “shotty” cervical nodes 5 trigger points tender Upper abdo quadrants tender Remainder normal
What additional history would be helpful?
What investigations should be done?
IMPORTANT HISTORY
FATIGUE Onset Duration Severity (% of N) Provoking Factors
(exercise?) Relieving Factors
(wkends, sleep?) OTHER SYMPTOMS
Arthralgia, myalgia, sore throat, neuro, depression bowel habits,
SLEEP Duration Quality Restorative? Use of ETOH, caffeine Narcolepsy “flags”
Daytime napping Hypnagogic hallucin. Cataplexy Sleep paralysis
Functional Somatic Syndromes
Several related syndromes characterized by:
symptoms, suffering and disability
rather than
demonstrable tissue abnormality
Examples:Examples:
• chronic fatigue syndrome (CFS)chronic fatigue syndrome (CFS)• multiple chemical sensitivitiesmultiple chemical sensitivities• sick building syndromesick building syndrome• fibromyalgiafibromyalgia• silicone breast implant diseasesilicone breast implant disease• chronic whiplash / other pain synd.chronic whiplash / other pain synd.• irritable bowel syndromeirritable bowel syndrome• othersothers
Characteristics:Characteristics:
• explicit and highly elaboratedexplicit and highly elaborated
self-diagnosisself-diagnosis
• symptoms may be refractory to symptoms may be refractory to reassurance, explanation, and reassurance, explanation, and standard treatmentsstandard treatments
Characteristics (cont’d)Characteristics (cont’d)
• high rates of co-occurrencehigh rates of co-occurrence
• similar epidemiologysimilar epidemiology
• higher than expected psychiatrichigher than expected psychiatric
comorbiditycomorbidity
Characteristics (concl’d):Characteristics (concl’d):
• suffering worsened by “self-perpetuating,suffering worsened by “self-perpetuating, self-validating cycle in which common,self-validating cycle in which common, endemic , somatic symptoms are incorrectlyendemic , somatic symptoms are incorrectly attributed to serious abnormality, attributed to serious abnormality, reinforcing the patient’s belief that he or shereinforcing the patient’s belief that he or she has a serious disease”.has a serious disease”.
Barsky and Borus. Ann Intern Med 1999:130:910-921.Barsky and Borus. Ann Intern Med 1999:130:910-921.
Incidence of somatic symptoms:Incidence of somatic symptoms:
Typical adult has one common symptomTypical adult has one common symptom eg. Aching, every 4-6 days eg. Aching, every 4-6 days
81% of healthy college students report81% of healthy college students report>> 1 somatic symptom q3days. 1 somatic symptom q3days.
Amplification and Maintenance of Somatic Symptoms
Five Factors:
1. The belief that one is sick
2. Future expectations and the Role of Suggestion
3. The Sick Role
4. Stress and Distress.
5. Political, Economic, and Legal issues
Amplification and Maintenance of Somatic Symptoms
1. The belief that one is sick Effect of cognitive beliefs on interpretation of current
symptoms. e.g. hypertension and absenteeism Effect of cognitive beliefs on interpretation and
recall of past symptoms
e.g. healthy volunteers given imaginary diagnosis Amplified through self-scrutiny, medical scrutiny,
media / public health attention, advocacy groups
Amplification and Maintenance of Somatic Symptoms
2. Future expectations and the Role of Suggestion
Cognitive processing of current bodily sensations guided by expectations of what we will experience next.
e.g. ASA for UAP – 6 X dropouts for GI symptoms (- endoscopy) if consent form explicitly mentioned
Amplification and Maintenance of Somatic Symptoms
3. The Sick Role
– social labeling theory:
“… the connotations and implications of the label we
apply to a condition or state influence the outcome of
that condition or state.”
- changes interactions with family, employer & physician
Amplification and Maintenance of Somatic Symptoms
4. Stress and Distress.– Exacerbates and perpetuates physical symptoms– lowers threshold for medical help seeking– ambiguous body sensations more likely attributed to
disease.
Amplification and Maintenance of Somatic Symptoms
5. Political, Economic, and Legal Issues
political climate of entitlement sense of belonging to a group secondary gain e.g. prolonged rehab. in workers
compensation
2. Chronic Fatigue Syndrome
“…fatigue is very common, CFS is not ”.
Caplan. CMAJ 1998;159(5):519-520.
CDC Criteria for CFS:
1. Fatigue > 6 mos., resulting in decrease in activities of > 50%.
and
2. All of: - New or definite onset - Not from ongoing exertion
- not alleviated by rest
and
CDC Criteria for CFS (concl’d):
> 4 of the following, present con-currently for > 6 mos.:- impaired memory/concentration- sore throat- tender cervical/axillary lymph nodes- myalgias- arthralgias- new headache- unrefreshing sleep- Post-exertional malaise
3.Diagnostic Strategy
A. Prolonged fatigue > 1 mo., < 6 mo.- Hx and Px- Mental status, psych, neuro as indicated- Lab: CBC, lytes, urea, Cr, glucose,
Ca++, phos, ALT, ALP, protein, albumin, TSH, urinalysis, ?ESR ?Fe Sat
- Additional tests as indicated*
*Additional tests as indicated:
- ANA, RF, C3, C4, CH50
- Quantitative Ig’s (serum, urine)– Cortisols, CK’s– HCV, HBV, HIV, CMV, toxo– TB skin test– Lyme serology– Sleep Study
Other cause of disease Identified?
YES: Manage as per diseaseNO:
B. Chronic Fatigue > 6 mos.:
Meet the CDC criteria?
Yes: Do you really want to make this diagnosis?No: Idiopathic chronic fatigue.
4. Treatment Strategies:
1. R/O diagnosable disease as per diagnostic strategy.
2. Treat psychiatric comorbidity.
3. Form therapeutic alliance with patient
4. Make restoration of function the goal of treatment
5. Provide limited reassurance
6. Cognitive Behavioral therapy?
7. Other options
4. Treatment Strategies:
1. R/O diagnosable disease (diagnostic strategy)
– Try not to foster sick role
– negative findings rarely reassure these patients
– risk of iatrogenesis.
4. Treatment Strategies:
2. Treat psychiatric comorbidity.
– Major depression, panic disorder
– somatic symptoms = probability of
psychiatric diagnosis
4. Treatment Strategies:
3. Form therapeutic alliance with patient
– acknowledge and legitimize patient’s suffering.– discourage sick role.– reassure that you will not abandon.
4. Treatment Strategies:
4. Make restoration of function the goal
– coping rather than curing
– realistic, incremental goals,
i.e. gently graduated exercise
– active rather than passive role
“not waiting to be cured” but “taking control of self-cure”
4. Treatment Strategies:
5. Provide limited reassurance
– “no life-threatening illness found”
– describe “amplification” process
4. Treatment Strategies: What’s the Evidence?
6. Cognitive Behavioral therapy
– Positive and negative randomized trials of varying
quality, and relatively small numbers.
– reexamines health beliefs and expectations
– explores effects of sick role and stress on symptoms
– muscle relaxation, graduated exercise, desensitization
THE STRESS REACTION CYCLE
External Stressors
Internal Stressors
Perceptual Appraisal
STRESSREACTION
acute hyperarousal followed by normalization
Disregualation = ChronicChronic HyperarousalHyperarousal
HBPArrhythmiassleep disprderschronic painschronic illnessanxiety
Maladaptive Coping
Self-destructive behaviours
overworkinghyperactivityovereating
harmful conditioningssubstance dependency
BreakdownBreakdown
Physical exhaustionPsychological exhaustionloss of energy, enthusiasmdepressiongenetic predispositionsMI, cnacer, chronic illness
(adapted fromJ. Kabat-Zinn)
Pain Centred Life
Function CentredLife
Adequate AnalgesiaEducationExerciseBreath & Relaxation
IncreasedActivities
Improved Conditioning
Improved Function
IncreasedControl
Improved Self-esteem
Improved Motivation
LETTING GO
Brain
Muscle & Fascia
SensoryFeedback
Characteristics:blood supply
metabolism
resting tone
contractility & power
flexibility & elasticity
Autonomic NSCentral NSHormonal system (sex hormone, cortisol, adrenaline, neuropeptides etc.)
TraumaEmotionsPosture
Muscle tensionIncreased tone
PAIN
CHRONIC MUSCLE CONTRACTION
Exercise, Stretching, Breathing & Relaxation Relaxation Practices
Exercise, Stretching, Breathing & Relaxation Relaxation Practices
4. Treatment Strategies:
7. Other options:
– low dose SSRI’s, TCA’s: no consistent response
– modafinil (alertec): few studies
– complementary therapies. No evidence from RCT’s
Depression Very common problem in primary
practice 10% of men over lifetime 20% of women over lifetime
May be even more prevalent in medical patients up to 40% with chronic illness
Depression in Medicine Depression more common in
following illnesses: stroke dementia diabetes heart disease renal disease cancer
Depression and Drug Tx certain drugs have been linked to onset of
depressive symptoms common offenders:
steroids, calcium channel blockers, digoxin cohort studies
withdrawal of psycho-stimulants benzos, barbituates, morphine, levo-dopa
perhaps ACEi, statins B-blockers controversial
Why should we care? Prognosis of medical diseases
worse in depressed patients 15 months post onset of depression,
mortality rates are 4 times that of age matched controls!!!
Depressed patients admitted to NH are 1.5 times more likely to die within a year
Post MI, depression is an important marker of prognosis as important as LV function
incidence in stroke patients very high between 25-80% range is large b/c difficult to make
diagnosis
Cancer and depression
estimates vary, but expect that depressed patients have mortality rates 10-20% greater than matched counterparts
Diagnosis often difficult medical patients often have somatic
complaints GI upset, headache, fatigue etc.
important to r/o other causes for complaints hypothyroid, anemia etc.
rating scales available (+ we have them!)
DSM 4 Criteria
Must have one of: depressed mood most of the time decreased interest/pleasure in nearly
all activities Plus, must have 5 of the following
during a 2 week period:
DSM 4 Criteria
weight change sleep change observed agitation or retardation fatigue or loss of energy feelings of worthlessness or excessive
guilt unable to concentrate / indecisiveness recurrent thoughts of death
Minor Depression patients and doctors may want to
attribute mood to current life stress I.e. adjustment disorder this is characterized as a minor
depression most common type of depression becomes problematic if leads to
social dysfunction, or persists longer than 2 months
Course and Prognosis untreated major depression:
40% resolve spontaneously within 6 - 12 months
20% resolution is incomplete sub-clinical symptoms persist for years
40% depression continues depression is usually recurrent
Course and Prognosis
depression is usually recurrent 70% recurrence after 2 episodes 90% recurrence after 3 episodes
thoughts of death are common 1 in 8 suicide attempts are successful risk factors for suicide:
medical illness, ETOH, male, Caucasian, presence of psychotic symptoms, social isolation, history of previous attempts, and a plan
Treatment main modalities include
psychotherapy drug treatment electro-convulsant therapy
should be individualized
Psychotherapy recent studies do show it to be as
effective as medication 40-50% improve BMJ 2000;320:26-30
perhaps best suited to less severe forms of depression in a highly motivated patient
Medications three main groups of drugs:
SSRI TCAs MAOI
occasionally for refractive forms: lithium valproate thyroid supplementation
Medications in general, need 6 week trial to see
effect try to adjust dose to achieve
benefits at lowest possible dose usually continue therapy for 6
months to 2 years relapses usually occur within 2
months of discontinuation; taper slowly
SSRI Most commonly used safer in overdose than TCAs some meta-analyses say less
effective than TCAs: other say equal
fluoxetine (Prozac) safe in pregnancy
SSRI - Common Side Effects GI:
nausea, diarrhea, weight gain neuro:
headache, sedation, paresthesia insomnia, poor memory, agitation
other: sexual dysfunction
SSRI - Rare Side Effects Neuro:
extrapyramdal - dystonias, akathesia b/c of serotonin mediated inhibition of
dopaminergic pathways Cardiac
case reports of a fib, bradycardia, syncope
may have class 1,4 properties and be pro-arrhythmic
SIADH
SSRI - Serotonin Syndrome Insidious, may be fatal
usually seen when 2 or more drugs enhance serotonin activity
present as: confused, agitated, fever, shivering,
diaphoretic, diarrhea, ataxic, hyper-reflexic, myoclonus
tx: stop meds +/- anti-sertoninergics (BB)
SSRI - OD Rarely fatal
if fatal, usually b/c of what it is combined with
moderate OD - 30* dose - are nauseated, drowsy
high - 75* - may have seizures, ECG changes and further decreased LOC
supportive care mainstay of treatment
TCAs until recently, most common drugs
used to treat depression decrease use attributed to addition of
SSRI to market very effective treatment
approx. 50-60% improve may still be 1st line for severe
depression
TCAs inhibit re-uptake of mono-amines,
noradrenaline and serotonin at nerve endings
many possible side effects, especially in the elderly
TCAs - Side Effects anti-cholinergic:
dry mouth, nausea, constipation, urinary retention, mydriasis and cycloplegia
cardiovascular: postural hypotension, tachycardia
neurologic: fine tremor, dizziness, ataxia drowsiness
TCA - Overdose can be rapidly fatal were the 4th most common OD within 6 hours:
CNS depression, seizures respiratory depression CVcollapse, QRS prolongation and VT
quinidine like effects
TCA - OD - Basic Treatment symptoms develop within 1-2 hours undergoes entero-hepatic circulation
repeated activated charcoal correct acid-base - ventilator,
NaHCO3 treat hypotension arrhythmias - NaHCO3, lidocaine,
pacing seizures - benzos or dilantin
MAOI increases levels of noradrenaline,
dopamine and 5-hydroxytryptamine
usually reserved for atypical depression: weight gain excessive sleep marked anxiety / obsessional features
MAOI - Side Effects common:
weight gain drowsiness, agitation postural hypotension
interactions may cause hypertension: tyramine in cheese, herring, red wines dopamine - other antidepressants
must give at least 2 week wash-out period
ECT usually reserved for:
imminent suicide psychotic depression catatonia
very effective usually need 6-8 treatments over 3
weeks
ECT - Side Effects can develop short-term retrograde
amnesia also can get hypertensive surge
sympathetic mediated b/c done under general
anaesthesia, other potential complications include aspiration pneumonia etc.
Special Considerations in Elderly age-related physiologic changes
may alter pharmacokinetics reduce flow to liver, kidney decreased enzyme activity
usually on multiple medications increases potential for drug
interactions “start low and go slow”
Special Considerations in Elderly TCAs metabolized by P-450
common inhibitors cipro, biaxin, flagyl, amiodarone, fluconazole
narrow therapeutic range increases possible side effects
SSRI prozac, zoloft, paxil, luvox all inhibit
P450 careful with haldol, coumadin, lithium
Conclusions depression is common in our patient
population elderly, chronic illnesses often present with somatic complaints
therapy is effective ideally managed by GP, or someone who
can see patient frequently many side-effects, but SSRI generally well
tolerated